| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/02/2008 | CN100378090C Substituted dioxopentacyclic derivative and its use in preparing neuro regulator |
| 04/02/2008 | CN100377734C Extract of plant dendrobii caulis and preparing process and use thereof |
| 04/02/2008 | CN100377707C Application of cucoline in preparation of medicine for treating macular degeneration, pigmentary degeneration of retina and diabetes retinosis |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | US7351686 Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
| 04/01/2008 | US7351524 Diagnostics and therapeutics for macular degeneration-related disorders |
| 04/01/2008 | US7351407 Administering agents such as GW-8510, purvalanol A, roscovitine to inhibit expression, signaling or biological functions of connective tissue growth factor |
| 04/01/2008 | CA2471952C Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 04/01/2008 | CA2288726C Eyedrops containing a loratadine metabolite |
| 03/27/2008 | WO2008035756A1 Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin |
| 03/27/2008 | WO2008011560A3 Benzothiophene inhibitors of rho kinase |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2008005869A3 Infant formulas for early brain development |
| 03/27/2008 | WO2007119098A3 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity |
| 03/27/2008 | WO2007084314A3 MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 03/27/2008 | US20080076814 Hexahydro-Cyclooctyl Pyrazole Cannabinoid Modulators |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076793 Use of an ascomycin for the treatment of blepharitis |
| 03/27/2008 | US20080076766 Piperidine Derivatives As Renin Inhibitor |
| 03/27/2008 | US20080076742 retinopathy of prematurity, diabetic retinopathy and macular degeneration; inhibiting retinal endothelial cell capillary morphogenesis, or inhibiting retinal angiogenesis; administering vitamin D; calcitriol; ergocalciferol; cholecalciferol |
| 03/27/2008 | US20080076735 Cytoskeletal active compounds, composition and use |
| 03/27/2008 | US20080076733 novel synthetic thiolatocobalamin; protects animal cells against oxidative stress damage; dietary supplement; also with vitamin B6 and a folate; cardiovascular disease, cerebrovascular disease, peripheral vascular disease, glaucoma, Alzheimer's disease, and dementia |
| 03/27/2008 | US20080075790 Self preserved aqueous pharmaceutical compositions |
| 03/27/2008 | US20080075787 Therapeutic Agent For Ophthalmic Diseases |
| 03/27/2008 | US20080075757 Dispersions of microemulsions in hydrogels for drug delivery |
| 03/27/2008 | US20080075756 Enhancing regeneration of lens cells in mammals after endocapsular extraction by filling a lens capsule bag with an injectable material comprising acrylated polysiloxane; intraocular lenses; cataracts, vision defects; coating lense with viscoelastic hyaluronic acid, cellulose, and/or collagen |
| 03/27/2008 | US20080075755 Macular degeneration, choroidal or retinal neovascularization, or ocular inflammation; administering a poxvirus viral complement interfering protein (VCIP) |
| 03/27/2008 | US20080075687 Ophthalmic compositions containing a synergistic combination of three polymers |
| 03/27/2008 | US20080075670 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1902731A1 Preventive or remedy for glaucoma |
| 03/26/2008 | EP1902725A2 Revascularization of ischemic retinal tissue |
| 03/26/2008 | EP1902068A1 Egfr inhibitors promote axon regeneration |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901755A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 03/26/2008 | EP1901724A1 Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | CN101151263A Substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151045A Methods for suppressing neovascularization using EphrinB2 |
| 03/26/2008 | CN101151038A Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
| 03/26/2008 | CN101151034A Meninges nerve cell protector containing prostaglandin F2alpha derivative as effective component |
| 03/26/2008 | CN101147764A Plant extracting liquid capable of relieving eye disease |
| 03/26/2008 | CN101147726A Good stability chloromycetin eyedrop and preparation method thereof |
| 03/26/2008 | CN101147524A Xylitol chewing gum containing compound medicine and food dual-purpose preparation and its preparation technique |
| 03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348306 Peptide with a sequence selected from the group consisting of Ser-Leu-Ile-Gly-Arg-Leu-NH2, and trans-cynnamoyl-Leu-Ile-Gly-Arg-Leu-ornithine-NH2 combined with amastatins for activation of protease activated receptor-2; eye drop solution for contact lenses |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | CA2416867C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 03/25/2008 | CA2319217C Pharmaceutical compositions |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2228281C Use of l-carnitine and acyl l-carnitines for lowering ceramide levels |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032222A2 Treatment of vertigo with acetyl-l-leucine |
| 03/20/2008 | WO2007133983A3 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/20/2008 | WO2007065021A3 A predictive tool for hyaluronidase treatment success |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070958 Therapeutic Agent for Keratoconjunctival Disorder |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070922 DDPIV inhibitor: selected from (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine, vildagliptin, Sitagliptin, saxagliptin; PDGF receptor tyrosine kinase inhibitor: selected from imatinib, imatinib methanesulfonate; impaired glucose metabolism; impaired glucose tolerance |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070908 Compositions including antibiotics and methods for using same |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070834 Cyclosporin Compositions |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | DE102006040278A1 Treatment of Charles-Bonnet syndrome, involves administration of serotonin reuptake inhibitor, e.g. venlafaxine or citalopram, to cause rapid and permanent eradication of hallucinations |
| 03/20/2008 | CA2663206A1 Treatment of vertigo with acetyl-l-leucine |
| 03/20/2008 | CA2662554A1 Compounds for the treatment of angiogenesis |
| 03/19/2008 | EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 03/19/2008 | EP1899295A2 Prostaglandin derivatives |
| 03/19/2008 | EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1429725B1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1246628A4 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |